Supply Chain

New York-based Bristol-Myers Squibb stock dropped 18 percent after its single-agent lung cancer drug Opdivo did not perform as hoped in a late-stage trial, Bloomberg reported.

Frazer, Pa.-based Cephalon — a subsidiary of Israel-based Teva Pharmaceuticals — reached a $125 million settlement with 48 states after an investigation found Cephalon purposefully delayed generic versions of its sleep disorder drug Provigil.

Hertfordshire, England-based Mylan — one of the largest generics and specialty pharmaceutical companies in the world, with U.S. headquarters in Pittsburgh — acquired Meda pharmaceuticals.

For a rush order, a drug courier drove a drug that once saved the life of a girl with a brain-eating amoeba infection from Orlando, Fla., to Medical University of South Carolina Health in Charleston to treat another patient with…

CVS Health is dropping two popular brand-name drugs in exchange for biosimilars of lower cost in an effort to curb prescription drug expenses, The Wall Street Journal reported. 

Minority Business News USA has named the recipients of its "2016 Champions of Supplier Diversity" list.

Drugmaker Pfizer has acquired Bamboo Therapeutics, a privately held biotechnology company based in Chapel Hill, N.C., focused on developing gene therapies to treat patients with certain rare diseases.

During the Democratic National Convention, Democratic politicians criticized the pharmaceutical industry for raising prescription drug prices. However, viewers at home were flooded with advertisements promoting drugs during commercial breaks, according to STAT.

Teva Pharmaceuticals today issued a voluntary recall of seven lots of amikacin sulfate injection vials due to the possible presence of glass particulate matter in the drug.

While sales of the popular vaccine Prevnar fell short, Pfizer still reported better-than-expected revenue thanks to strong sales from new treatments.